- Volume 13 Issue 2
DOI QR Code
Clinico-Pathological Significance of MHC-I Type Chain-associated Protein A Expression in Oral Squamous Cell Carcinoma
- Wang, Jie (Department of Immunology, Xiangya Medical School, Central South University) ;
- Li, Chao (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
- Yang, Dan (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
- Jian, Xin-Chun (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
- Jiang, Can-Hua (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University)
- Published : 2012.02.29
The current research concerns the clinicopathological significance of MHC class I chain-related protein A (MICA) expression in oral squamous cell carcinomas (OSCCs). The expression and location of MICA protein in 14 normal oral mucous and 45 cancerous and para-cancerous tissues were assessed by immunohistochemistry and levels of MICA mRNA expression in 29 cancerous and para-cancerous tissues were determined by the real-time polymerase chain reaction. Data were analyzed with the SPSS16.0 software package. MICA was found to be located in the cytoplasm and plasma membrane. Expression was higher in para-cancerous than in cancerous tissues (P < 0.05). However, no statistical difference was found between the following: 1) para-cancerous tissue with normal mucosa; 2) normal mucosa with cancerous tissue;and 3) among different clinicopathological parameters in OSCC (P > 0.05). The level of MICA mRNA was higher in OSCCs than in para-cancerous tissues, and was correlated with the regional lymph node status and disease stage (P < 0.05). The levels of MICA protein and mRNA expression differ among normal oral mucosa, para-cancerous tissue, and cancerous tissue. MICA may contribute to the tumorigenesis and progression of OSCC.
Carcinoma squamous cell;MHC class I-related chain A;immunohistochemistry;polymerase chain reaction
Supported by : Natural Science Foundation of China
- Bauer S, Groh V, Wu J, et al (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-9. https://doi.org/10.1126/science.285.5428.727
- Diefenbach A, Jensen ER, Jamieson AM, et al (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature, 413, 1652-71.
- Fuertes MB, Girart MV, Molinero LL, et al (2008). Intracellular Retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol. 180, 4606-14. https://doi.org/10.4049/jimmunol.180.7.4606
- Jinushi M, Takehara T, Tatsumi T, et al (2003). Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer, 104, 354-61. https://doi.org/10.1002/ijc.10966
- Kaiser BK, Yim D, Chow IT, et al (2007). Disulphide-isomeraseenabled shedding of tumour-associated NKG2D ligands. Nature, 447, 482-6. https://doi.org/10.1038/nature05768
- Li P, Morris DL, Willcox BE, et al (2001). Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol, 2, 443-51. https://doi.org/10.1038/87757
- Liu CJ, Lui MT, Chen HL, et al (2007). MICA and MICB overexpression in oral squamous cell carcinoma. J Oral Pathol Med, 36, 43-7.
- Madjd Z, Spendlove I, Moss R, et al (2007). Upregulation of MICA on high-grade invasive operable breast carcinoma. Cancer Immun, 7, 17.
- Ostberg JR, Dayanc BE, Yuan M, et al (2007). Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol, 82, 1322-31. https://doi.org/10.1189/jlb.1106699
- Sutherland CL, Chalupny NJ, Schooley K, et al (2002). UL16- binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol, 168, 671-9. https://doi.org/10.4049/jimmunol.168.2.671
- Tamaki S, Sanefuzi N, Kawakami M, et al (2008). Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol, 69, 88-93. https://doi.org/10.1016/j.humimm.2008.01.010
- Waldhauer I, Goehlsdorf D, Gieseke F, et al (2008). Tumorassociated MICA is shed by ADAM proteases. Cancer Res, 68, 6368-76. https://doi.org/10.1158/0008-5472.CAN-07-6768
- Wu J, Song Y, Bakker AB, et al (1999). An activating immunoreceptor complex formed by NKG2D and DAP10. Science, 285, 730-2. https://doi.org/10.1126/science.285.5428.730
- Xiao P, Xue L, Che LH, et al (2008). Expression and roles of MICA in human osteosarcoma. Histopathology, 52, 640-2. https://doi.org/10.1111/j.1365-2559.2008.02989.x
- Zhang C, Niu J, Zhang J, et al (2008). Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors. Cancer Sci, 99, 1279-86. https://doi.org/10.1111/j.1349-7006.2008.00791.x
- Clinical Significance of Soluble Major Histocompatibility Complex Class I Chain-related A in Renal Cell Carcinoma Patients vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5651
- Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma vol.35, pp.1, 2015, https://doi.org/10.3892/or.2015.4338